Evidence map›Paper›PMID 39444170›Full record

ArticleJournal of midwifery & women's health

Implementing Best Practice When Screening Birthing People for a Substance Use Disorder.

Sheila Kaufman, Patricia D Suplee, Damali M Campbell-Oparaji, Julie Blumenfeld

Abstract read
In one paragraph

Article in Journal of midwifery & women's health. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sheila KaufmanVirtua Health, Camden, New Jersey.ORCID 0009-0001-0984-3464
Patricia D SupleeSchool of Nursing-Camden, Rutgers, The State University of New Jersey, Camden, New Jersey.
Damali M Campbell-OparajiDepartment of Obstetrics and Gynecology, Rutgers New Jersey Medical School, Newark, New Jersey.
Julie BlumenfeldMidwifery Program, Division of Advanced Nursing Practice, School of Nursing, Rutgers, The State University of New Jersey, Newark, New Jersey.ORCID 0000-0003-2795-1941

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Screening for substance use disorder (SUD) is an essential part of antepartum care. Best practice for screening requires the use of a validated tool early in pregnancy to identify those at risk and to connect them with counseling and treatment. In many health systems and practices, urine toxicology testing is erroneously employed as a SUD screening tool despite consistent recommendations against its routine use. The results are often misinterpreted as diagnostic of SUD and can have harmful downstream effects for pregnant and birthing people. This Clinical Rounds reviews the tools available for evidence-based SUD screenings in pregnancy care, pitfalls of urine toxicology testing, and ways in which midwifery care is well-positioned to implement evidence-based screening practices in pregnancy care.

Indexed as

Mass ScreeningMidwiferyPregnancy ComplicationsSubstance-Related DisordersFemaleHumansPractice Guidelines as TopicPregnancyPrenatal CareSubstance Abuse DetectionTeaching Roundscertified midwifecertified nurse‐midwifemidwiferyprenatal careracismsubstance abuse detectionsubstance‐related disorderstoxicology

Identifiers

PMID39444170
PMCPMC11622360

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.